Semax Source

Semax Research References: Full Citation List with DOIs and PubMed Links

This page lists all 21 peer-reviewed sources cited across this Semax literature digest. Every citation includes the full bibliographic record, DOI, and PubMed or primary-source URL. Citations are numbered to match the inline [N] markers used throughout the site.

  1. Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, Kamensky AA, Grivennikov IA, Engele J, Myasoedov NF. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. Journal of Neurochemistry. 2006. DOI: 10.1111/j.1471-4159.2006.03658.x — PubMed 16635254
  2. Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, Dubynina EV, Novosadova EV, Andreeva LA, Alfeeva LY, Kamensky AA, Grivennikov IA, Myasoedov NF, Engele J. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006. DOI: 10.1016/j.brainres.2006.07.108 — PubMed 16996037
  3. Inozemtseva LS, Dolotov OV, Lebedeva OS, Grivennikov IA, Myasoedov NF. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neuroscience Letters. 2006. DOI: 10.1016/j.neulet.2005.11.047 — PubMed 16362768
  4. Sudarkina OY, Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, Sevan'kaeva LE, Valieva LV, Remizova JA, Dmitrieva VG, Gubsky LV, Myasoedov NF, Limborska SA, Dergunova LV. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. International Journal of Molecular Sciences. 2021. DOI: 10.3390/ijms22126179 — PubMed 34201112
  5. Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, Skvortsova VI, Myasoedov NF, Dergunova LV. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014. DOI: 10.1186/1471-2164-15-228 — PMC3987924
  6. Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell and Molecular Neurobiology. 2010. DOI: 10.1007/s10571-009-9432-0 — PubMed 19633950
  7. Shadrina MI, Dolotov OV, Grivennikov IA, Slominsky PA, Andreeva LA, Inozemtseva LS, Limborska SA, Myasoedov NF. Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neuroscience Letters. 2001. DOI: 10.1016/s0304-3940(01)01994-2 — PubMed 11457573
  8. Shadrina M, Kolomin T, Agapova T, Agniullin Y, Shram S, Slominsky P, Lymborska S, Myasoedov N. Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. Journal of Molecular Neuroscience. 2010. DOI: 10.1007/s12031-009-9270-z — PubMed 19662538
  9. Shevchenko KV, Nagaev IIu, Alfeeva LIu, Andreeva LA, Kamenskii AA, Levitskaia NG, Shevchenko VP, Grivennikov IA, Miasoedov NF. Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration. Bioorganicheskaia Khimiia. 2006. DOI: 10.1134/s1068162006010055 — PubMed 16523722
  10. Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorganicheskaia Khimiia. 2001. DOI: 10.1023/a:1011373002885 — PubMed 11443939
  11. Slominsky PA, Shadrina MI, Kolomin TA, Stavrovskaya AV, Filatova EV, Andreeva LA, Illarioshkin SN, Myasoedov NF. Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Doklady Biological Sciences. 2017. DOI: 10.1134/S0012496617030048 — PubMed 28702721
  12. Volodina MA, Sebentsova EA, Glazola NYu, et al. Correction of Long-Lasting Negative Effects of Neonatal Isolation in White Rats Using Semax. Acta Naturae. 2012. DOI: PMID 22708068 — PMC3372995
  13. Volodina MA, Sebentsova EA, Glazova NYu, Levitskaya NG, Andreeva LA, Manchenko DM, Kamensky AA, Myasoedov NF. Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats. Bulletin of Experimental Biology and Medicine. 2012. DOI: 10.1007/s10517-012-1574-2 — PubMed 22803132
  14. Grivennikov IA, Dolotov OV, Zolotarev YA, Andreeva LA, Myasoedov NF, Leacher L, Black IB, Dreyfus CF. Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons. Restorative Neurology and Neuroscience. 2008. DOI: PMID 18431004 — PubMed 18431004
  15. Kurysheva NI, Shpak AA, Ioileva EE, et al. Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone. Vestnik Oftalmologii. 2001. DOI: not available (Russian-language article, PMID verified) — PubMed 11569188
  16. Inozemtseva LS, Yatsenko KA, Glazova NYu, Kamensky AA, Myasoedov NF, Levitskaya NG, Grivennikov IA, Dolotov OV. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress. European Journal of Pharmacology. 2024. DOI: 10.1016/j.ejphar.2024.177068 — PubMed 39442746
  17. Shevchenko KV, Nagaev IYu, Andreeva LA, Alfeeva LYu, Myasoedov NF. Study of proteolysis of Semax analogues with different N-terminal amino acids by carboxypeptidases. Doklady Biological Sciences. 2013. DOI: 10.1134/S0012496613030101 — PubMed 23821053
  18. Shevchenko KV, Nagaev IYu, Andreeva LA, Shevchenko VP, Myasoedov NF. Stability of Semax acetyl to proteolysis in various biological media. Doklady Biological Sciences. 2013. DOI: 10.1134/S0012496613020166 — PubMed 23652441
  19. Volodina MA, et al. The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons. Bulletin of Experimental Biology and Medicine. 2025. DOI: 10.1007/s10517-025-06501-z — Springer
  20. Tomasello MF, Di Rosa MC, Naletova I, Sciacca MMF, Giuffrida A, Maccarrone G, Attanasio F. Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Abeta by Metal Ion Stripping and Redox Silencing. Bioinorganic Chemistry and Applications. 2025. DOI: 10.1155/bca/4226220 — PMC12151629
  21. Liu et al. Semax peptide targets the mu opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. British Journal of Pharmacology. 2025. DOI: 10.1111/bph.70122 — PubMed 40692165